Skip to content

    Rallis India

    RALLISGood
    Chemicals·21 Jan 2026
    Management Summary

    Rallis India reported a strong Q3 FY26 with revenue growing 19% to ₹623 crores, driven by a significant 28% volume growth despite an 8% price de-growth. EBITDA increased by 29% to ₹58 crores. However, Profit After Tax declined 81% to ₹2 crores due to an exceptional gratuity provision of ₹40 crores. Key segments like Seeds and Exports showed robust growth, while the domestic agrochemical market faced demand weakness.

    Highlights

    8
    • Q3 FY26 Revenue stood at ₹623 crores, marking a 19% YoY growth from ₹522 crores.

    • Overall volume growth was approximately 28%, despite a pricing de-growth of 8%.

    • Q3 FY26 EBITDA increased by 29% to ₹58 crores.

    • Profit After Tax (PAT) for Q3 FY26 was ₹2 crores, an 81% decline YoY from ₹11 crores, impacted by a ₹40 crores gratuity provision.

    • Crop Care Segment grew by 18% to ₹580 crores in Q3 FY26.

    • Seeds Business Revenue surged 46% to ₹43 crores in Q3 FY26.

    • Exports (B2B) topline grew significantly by 73% to ₹129 crores.

    • Domestic (B2C) revenue registered a 13% growth to ₹391 crores.

    Concerns

    1
    • Weak agrochemical demand due to stressed demand drivers (weather issues, low crop prices)

    What Changed3

    vs Q4 FY26

    Guidance items10 → 5 (-5)Risks discussed4 → 5 (+1)Q&A highlights8 → 3 (-5)
    Key financials

    Metrics

    4

    Periods

    2

    Headline

    3
    • Revenue
      ₹623 Cr
      YoY+19.4%
    • EBITDA
      ₹58 Cr
      YoY+29.0%
    • PAT
      ₹2 Cr
      YoY-81.8%

    9M

    1
    • FY26 Revenue
      ₹2,441 Cr
      YoY+9%

    Segment breakdown

    Crop Care Segment (9M FY26)
    ₹1,991 Cr35.0%
    B2C Business (9M FY26)
    ₹1,401 Cr24.6%
    B2B Business (9M FY26)
    ₹590 Cr10.4%
    Crop Care Segment (Q3 FY26)
    ₹580 Cr10.2%
    Seeds Business (9M FY26)
    ₹450 Cr7.9%
    Domestic (B2C) (Q3 FY26)
    ₹391 Cr6.9%
    Exports (B2B) (Q3 FY26)
    ₹129 Cr2.3%
    Soil & Plant Health (Q3 FY26)
    ₹73 Cr1.3%
    CSM (Q3 FY26)
    ₹46 Cr0.8%
    Seeds Business (Q3 FY26)
    ₹43 Cr0.8%
    Treemap· Share of Revenue

    Guidance & targets

    4
    CategoryTargetPriority
    Sector Growth
    Agrochemical Market Growth
    3-4% to ~USD 9.6–10.0 bn
    Medium
    Revenue
    Seed Business Revenue
    INR1,000 crores
    Low
    Revenue
    Soil and Plant Health Business Revenue
    INR700-800 crores (4x from INR225 crores)
    Low
    Margin
    Overall Blended Margin Expansion
    500 basis points
    Low

    Risks & concerns

    7
    RiskSeverity

    Weak agrochemical demand due to stressed demand drivers (weather issues, low crop prices)

    Agrochemical demand remains weak, leading to industry-wide volume decline, impacting farmer interest in high-value products.Management acknowledged

    high

    Global competition and China overcapacity/dumping, capping realizations

    Pricing power is limited as global competition intensifies, with China as the primary supplier, capping realizations.Management acknowledged

    medium

    Rapid resets in key technicals (glyphosate/glufosinate/paraquat) can reprice on-hand inventory and compress margins

    Volatility in technical prices poses a risk to inventory valuation and potential margin compression.Management acknowledged

    medium

    Uncertainty in international business due to tariffs, geopolitical context, and softening crop prices

    Management is still assessing the situation, noting it's 'very uncertain environment right now' regarding international trade and crop prices in regions like Latin America.Management acknowledged

    medium

    Industry-wide inventory buildup in the system

    Management acknowledges elevated channel stocks but states they are careful in tracking placement and returns, indicating control over their own inventory.Analyst acknowledged

    medium

    Areas of Evasion(2)

    • Specific size of the unorganized market in soil and plant health
    • Precise quantification of Chinese VAT rebate impact

    Q&A highlights

    3

    “So I think you'll have to wait for some more information to filter in as I know it is applicable only from April. But it will certainly lead I mean if there's not too much a production happening for a particular AI, it should lead to some price increase and some consolidation in players.”

    This question addresses a significant external factor (Chinese policy change) that could impact the competitiveness and cost structure of Rallis India's export business and raw material sourcing.

    asked by Arjun Khanna

    3 min read6 chapters

    Detailed Narrative

    01

    Q3 FY26 Financial Performance and Key Drivers

    Rallis India delivered an encouraging Q3 FY26, with revenue growing 19% year-on-year to ₹623 crores from ₹522 crores in Q3 FY25. This growth was predominantly driven by a significant 28% increase in volumes, despite an 8% de-growth in pricing. EBITDA for the quarter rose 29% to ₹58 crores. However, Profit After Tax (PAT) saw an 81% decline to ₹2 crores, primarily due to an exceptional gratuity provision of ₹40 crores related to wage code implementation, which impacted profitability.

    02

    Segmental Performance and Growth Engines

    The Crop Care segment recorded an 18% growth, reaching ₹580 crores in Q3 FY26, fueled by volume expansion and new product promotions. The Seeds business demonstrated robust performance, with revenue soaring 46% to ₹43 crores, driven by healthy product placements in paddy, mustard, and wheat. The Soil & Plant Health category also grew 16% to ₹73 crores, benefiting from both price and volume increases and successful in-house production migration. Exports (B2B) showed strong momentum with a 73% topline growth to ₹129 crores, while Domestic (B2C) grew 13% to ₹391 crores.

    03

    Domestic and Global Agrochemical Market Context

    The domestic agrochemical market continues to face challenges, with weak demand attributed to weather issues and low crop prices, leading to an industry-wide volume decline. Farmer interest in high-value products has waned, as kharif crops traded 9-30% below Minimum Support Prices. Globally, the agrochemical market is projected to grow at a CAGR of ~5.5% to reach $75 billion by 2025, with herbicides being the largest category. Rabi acreage, however, is up ~3% YoY in wheat, oilseeds, and pulses, offering some support for Q4.

    04

    Strategic Initiatives and Product Innovation

    Rallis India is actively pursuing strategic initiatives to enhance its market position. During Q3 FY26, the company launched one new herbicide, 'Fateh Nxt,' contributing to a total of nine new product launches (seven herbicides and two fungicides) in the first nine months of FY26. A new biologicals platform, 'NuCode,' was introduced under the Soil and Plant Health category. Digital initiatives like 'Sampark Plus app' and the 'Idea2impact' open-innovation platform are being leveraged to improve demand generation, farmer engagement, and accelerate innovation.

    05

    Long-Term Aspirations for Growth and Margins

    Management outlined ambitious long-term aspirational targets for its key businesses. The company aims to grow its seed business to approximately INR1,000 crores and the Soil & Plant Health business to INR700-800 crores (a 4x increase from INR225 crores) within the next five years. These segments are identified as relatively high-margin businesses. Furthermore, Rallis India targets an overall blended margin expansion of 500 basis points over the next five years, driven by operating leverage and a focus on profitable growth, aspiring for double-digit revenue growth overall.

    06

    Impact of China and International Market Uncertainties

    The international business environment remains uncertain, with global competition from China continuing to exert pressure on realizations. China supplies a significant portion of key technicals globally, and the upcoming discontinuation of Chinese VAT rebates from April is a new development that could lead to price increases and industry consolidation. Management acknowledged the 'very uncertain environment' regarding international trade policies and geopolitical context, stating their dependence on technical procurement from China is still more than 40%.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.